Through this collaboration, Nanoscope Therapeutics will utilize Verana Health’s Qdata ® Retinitis Pigmentosa, which is a research-ready, real-world dataset that can be used to analyze patients with RP ...

A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at https://investors.alector.com. Replays of the ...

Neurodegenerative disorders present one of the most challenging fronts in modern medicine, with diseases like Alzheimer’s and Parkinson’s disease impacting ...

New research led by the University of Melbourne is helping to shed light on the aging process of the heart and how ...

Researchers identify associations between B12 levels currently accepted as normal and markers of neurological injury or ...

In an exceptionally rare case, a patient with a high genetic risk of developing Alzheimer's appears to have avoided his ...

New research has revitalized interest in the longstanding link between brain trauma and dementia by focusing on the vascular ...

A neurodegenerative disorder, MSA is so aggressive that within a few years, vibrant, active individuals are reduced to a ...

People over the age of 60 are more susceptible to Parkinson's disease. As China's population continues to age, this new medical breakthrough has sparked hope within both the academic and medical ...

Chinese scientists have discovered a novel therapeutic target for Parkinson's disease, a neurodegenerative condition ...

Announcing a new publication for Acta Materia Medica journal. The prevalence of depressive-like behavior is significantly higher in patients with cholestatic liver disease, leading to a notable ...

Exposure to B. bassiana fungus activated Toll receptors, leading to cell death throughout the fly brain. A new study ...